Answers are grounded in this paper and cite their sources.
It is challenging to treat renal pelvic cancer in a monofunctioning kidney and severe renal dysfunction while preserving renal function. A 78-year-old man with renal pelvic cancer and G4 chronic kidney disease was treated with high-dose adaptive radiotherapy using helical tomotherapy with a total dose of 74 Gy in 37 fractions. His serum creatinine level before radiotherapy was 2.15 mg/dl, which temporarily increased to 5.00 mg/dl at 9 months after radiotherapy, but gradually decreased to 2.05 mg/dl 2 years later with medical treatment. Follow-up MRI showed complete tumor regression 5.5 years after radiotherapy, and dialysis was avoided. High-dose adaptive radiotherapy may be a viable option for a monofunctioning kidney and severe renal dysfunction complicated by renal pelvic cancer.
No takes yet. Share an insight, caveat, or question.
Hama et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: